Polynucleotides encoding novel two splice variants of a human cell surface protein with immunologobulin folds, BGS5G and BGS5I
    11.
    发明申请
    Polynucleotides encoding novel two splice variants of a human cell surface protein with immunologobulin folds, BGS5G and BGS5I 审中-公开
    编码具有免疫球蛋白折叠的人细胞表面蛋白的新型两个剪接变体的多核苷酸,BGS5G和BGS5I

    公开(公告)号:US20040030098A1

    公开(公告)日:2004-02-12

    申请号:US10403847

    申请日:2003-03-28

    CPC分类号: C07K14/70503

    摘要: The present invention provides novel polynucleotides encoding BGS-5G, and BGS-5I polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel BGS-5G, and BGS-5I polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

    摘要翻译: 本发明提供了编码BGS-5G和BGS-5I多肽的新型多核苷酸,其片段及其同源物。 还提供了载体,宿主细胞,抗体以及用于产生所述多肽的重组和合成方法。 本发明还涉及将这些新型BGS-5G和BGS-5I多肽应用于诊断,治疗和/或预防与这些多肽相关的各种疾病和/或病症的诊断和治疗方法。 本发明还涉及用于鉴定本发明的多核苷酸和多肽的激动剂和拮抗剂的筛选方法。

    Compositions and methods for cancer screening
    13.
    发明申请
    Compositions and methods for cancer screening 审中-公开
    癌症筛查的组成和方法

    公开(公告)号:US20040029195A1

    公开(公告)日:2004-02-12

    申请号:US10333543

    申请日:2003-08-25

    发明人: Ramin Shiekhattar

    CPC分类号: G01N33/57484

    摘要: Methods for screening for cancer are provided which are based on the direct interaction of BRCA1 with the mammalian SWI/SNF complex through association with its BRG1 subunit. Also provided are compositions for modulating cellular proliferation by modulating chromatin remodeling activity in mammalian cells which targets a BRG1 subunit of the SWI/SNF complex.

    摘要翻译: 提供了筛选癌症的方法,其基于通过与其BRG1亚基相关联的BRCA1与哺乳动物SWI / SNF复合物的直接相互作用。 还提供了通过调节靶向SWI / SNF复合物的BRG1亚基的哺乳动物细胞中的染色质重塑活性来调节细胞增殖的组合物。

    Nucleic acids, proteins, and antibodies
    14.
    发明申请
    Nucleic acids, proteins, and antibodies 审中-公开
    核酸,蛋白质和抗体

    公开(公告)号:US20040009491A1

    公开(公告)日:2004-01-15

    申请号:US10264237

    申请日:2002-10-04

    CPC分类号: C07K14/47

    摘要: The present invention relates to novel polynucleotides associated with the plasma membrane, the polypeptides encoded by these polynucleotides herein collectively referred to as nullplasma membrane associated antigens,null and antibodies that immunospecifically bind these polypeptides, and the use of such plasma membrane associated polynucleotides, antigens, and antibodies for detecting, treating, preventing and/or prognosing disorders related to these novel polypeptides. More specifically, isolated nucleic acid molecules are provided encoding novel plasma membrane associated polypeptides. Novel polypeptides and antibodies that bind to these polypeptides are provided. Also provided are vectors, host cells, and recombinant and synthetic methods for producing these plasma membrane associated polynucleotides, polypeptides, and/or antibodies. The invention further relates to diagnostic and therapeutic methods useful for diagnosing, treating, preventing and/or prognosing disorders related to the novel polypeptides of the invention. The invention further relates to screening methods for identifying agonists and antagonists of polynucleotides and polypeptides of the invention. The invention further relates to methods and/or compositions for inhibiting or promoting the production and/or function of the polypeptides of the invention.

    摘要翻译: 本发明涉及与质膜相关的新型多核苷酸,由这些多核苷酸编码的多肽本文统称为“质膜相关抗原”,以及免疫特异性结合这些多肽的抗体,以及使用这种质膜相关多核苷酸,抗原 以及用于检测,治疗,预防和/或预测与这些新型多肽相关的疾病的抗体。 更具体地,提供编码新型质膜相关多肽的分离的核酸分子。 提供结合这些多肽的新型多肽和抗体。 还提供了用于产生这些质膜相关多核苷酸,多肽和/或抗体的载体,宿主细胞和重组和合成方法。 本发明还涉及用于诊断,治疗,预防和/或预测与本发明的新型多肽相关的疾病的诊断和治疗方法。 本发明还涉及用于鉴定本发明的多核苷酸和多肽的激动剂和拮抗剂的筛选方法。 本发明还涉及用于抑制或促进本发明多肽的产生和/或功能的方法和/或组合物。

    Immunoassay for cancer
    18.
    发明申请
    Immunoassay for cancer 审中-公开
    癌症免疫测定

    公开(公告)号:US20030224462A1

    公开(公告)日:2003-12-04

    申请号:US10162133

    申请日:2002-06-04

    发明人: George H. Parsons

    IPC分类号: G01N033/574 C07K016/30

    CPC分类号: G01N33/574 G01N33/6854

    摘要: The invention relates to new immunoassays using IgE type auto-antibodies specific for tumor antigens, especially prostate specific antigen (PSA). Such an assay can also be used to improve existing assays for PSA.

    摘要翻译: 本发明涉及使用针对肿瘤抗原特异性的IgE型自身抗体的新免疫测定法,特别是前列腺特异性抗原(PSA)。 这样的测定法也可用于改进PSA的现有测定。

    Novel gene expressed in prostate cancer
    19.
    发明申请
    Novel gene expressed in prostate cancer 失效
    在前列腺癌中表达的新基因

    公开(公告)号:US20030211520A1

    公开(公告)日:2003-11-13

    申请号:US10334561

    申请日:2002-12-30

    摘要: A novel testis-specific gene expressed in human prostate cancer, designated 22P4F11, is described. Analysis of 22P4F11 mRNA expression in normal prostate, prostate tumor xenografts, and a variety of normal tissues indicates that the expression of this gene is testis specific in normal tissues. The 22P4F11 gene is also expressed in human prostate tumors, in some cases at high levels. A full length cDNA encoding 22P4F11 is provided. The 22P4F11 transcript and/or protein may represent a useful diagnostic marker and/or therapeutic target for prostate cancer.

    摘要翻译: 描述了在人前列腺癌中表达的新型睾丸特异性基因,命名为22P4F11。 正常前列腺,前列腺肿瘤异种移植物和各种正常组织中22P4F11 mRNA表达的分析表明,该基因的表达在正常组织中是睾丸特异性的。 22P4F11基因也在人前列腺肿瘤中表达,在某些情况下也是高水平表达的。 提供了编码22P4F11的全长cDNA。 22P4F11转录物和/或蛋白质可以代表前列腺癌的有用的诊断标记物和/或治疗靶标。